Business Context and Reporting Period
Company: Assembly Biosciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 9, 2016
Context: The filing serves as a Regulation FD disclosure to furnish an investor presentation (Exhibit 99.1) intended for use in meetings with investors and others. The presentation is also available on the company's website.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to distribute a corporate presentation rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed within the text of this Form 8-K. The filing solely announces the availability of the November 2016 Corporate Presentation.
Guidance, Outlook, and Risks
Management Commentary: The company intends to use the attached presentation for investor communications starting November 9, 2016.
Legal Status of Information: The information contained in Item 7.01 and Exhibit 99.1 is furnished, not "filed," under Section 18 of the Securities Exchange Act of 1934. Consequently, it is not subject to the liabilities of that section nor incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Assembly Biosciences, Inc. Corporate Presentation November 2016) for actual financial data and strategic outlook.
- Verify the presentation content on the company's investor relations website at http://investor.assemblybio.com/index.cfm.
- Note that the presentation itself is not legally "filed" with the SEC for liability purposes under Section 18 of the Exchange Act.